NO20091875L - Genetisk ablasjon av PRP genceller ved anvendelse av en malsokt strategi for produksjon av serum - Google Patents

Genetisk ablasjon av PRP genceller ved anvendelse av en malsokt strategi for produksjon av serum

Info

Publication number
NO20091875L
NO20091875L NO20091875A NO20091875A NO20091875L NO 20091875 L NO20091875 L NO 20091875L NO 20091875 A NO20091875 A NO 20091875A NO 20091875 A NO20091875 A NO 20091875A NO 20091875 L NO20091875 L NO 20091875L
Authority
NO
Norway
Prior art keywords
smelly
prp gene
genetic ablation
production strategy
gene cells
Prior art date
Application number
NO20091875A
Other languages
English (en)
Inventor
Carola Schroder
Elisabeth Casademunt
Kim Bjornstrup
Original Assignee
Octagene Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octagene Gmbh filed Critical Octagene Gmbh
Publication of NO20091875L publication Critical patent/NO20091875L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0684—Cells of the urinary tract or kidneys
    • C12N5/0686—Kidney cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95—Protein-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en prionprotein (PrP)-fri immortalisert somatisk human cellelinje hvor begge allelene av PrP-genet har blitt fullstendig deletert ved homolog rekombinasjon. Oppfinnelsen tilveiebringer videre en fremgangsmåte for fremstilling av nevnte cellelinje og anvendelse derav for fremstilling av humane rekombinante proteiner som er egnet som biofarmasøytiske midler.
NO20091875A 2006-11-20 2009-05-13 Genetisk ablasjon av PRP genceller ved anvendelse av en malsokt strategi for produksjon av serum NO20091875L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06124427 2006-11-20
PCT/EP2007/062597 WO2008061995A2 (en) 2006-11-20 2007-11-20 Genetic ablation of the prp gene cells using a targeted promoter trap strategy for production of serum-free recombinant proteins as therapeuticals

Publications (1)

Publication Number Publication Date
NO20091875L true NO20091875L (no) 2009-07-28

Family

ID=37685785

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091875A NO20091875L (no) 2006-11-20 2009-05-13 Genetisk ablasjon av PRP genceller ved anvendelse av en malsokt strategi for produksjon av serum

Country Status (12)

Country Link
EP (1) EP2084269A2 (no)
KR (1) KR20090106474A (no)
CN (1) CN101605891A (no)
AU (1) AU2007324530A1 (no)
BR (1) BRPI0718989A2 (no)
CA (1) CA2670003A1 (no)
IL (1) IL198770A0 (no)
MX (1) MX2009005277A (no)
NO (1) NO20091875L (no)
RU (1) RU2009123458A (no)
WO (1) WO2008061995A2 (no)
ZA (1) ZA200903429B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2728900T3 (es) * 2010-05-12 2019-10-29 Janssen Biotech Inc Diferenciación de células madre embrionarias humanas
CN102277379B (zh) * 2011-08-18 2013-07-24 中国科学院遗传与发育生物学研究所 表达凝血因子viii的表达载体及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
ATE288484T1 (de) * 1991-11-14 2005-02-15 Charles Weissmann Transgene nicht-menschliche tiere ohne prionprotein
NZ512309A (en) * 1998-12-22 2003-05-30 Univ California Prion-free therapeutic formulations produced from somatic cells with an artificially altered prion protein (PrP) gene
AU2001247773A1 (en) * 2000-03-24 2001-10-08 University Of Massachusetts, As Represented By Its Amherst Campus Prion-free transgenic ungulates
AU2002242854A1 (en) * 2001-03-21 2002-10-03 Geron Corporation Use of telomerase reverse transcriptase to create homozygous knockout animals

Also Published As

Publication number Publication date
WO2008061995A2 (en) 2008-05-29
CA2670003A1 (en) 2008-05-29
RU2009123458A (ru) 2010-12-27
EP2084269A2 (en) 2009-08-05
KR20090106474A (ko) 2009-10-09
IL198770A0 (en) 2011-08-01
WO2008061995A3 (en) 2008-07-10
AU2007324530A1 (en) 2008-05-29
MX2009005277A (es) 2009-05-28
CN101605891A (zh) 2009-12-16
BRPI0718989A2 (pt) 2014-02-11
ZA200903429B (en) 2010-04-28

Similar Documents

Publication Publication Date Title
Hamm et al. Regulatory principles governing the maternal-to-zygotic transition: insights from Drosophila melanogaster
Gutiérrez-Caballero et al. Identification and molecular characterization of the mammalian α-kleisin RAD21L
Stephan et al. The Nse2/Mms21 SUMO ligase of the Smc5/6 complex in the maintenance of genome stability
A. Lea et al. Human germline genome editing
Wan et al. Maternal depletion of CTCF reveals multiple functions during oocyte and preimplantation embryo development
CY1120272T1 (el) ΠΑΡΟΧΗ mRNA ΓΙΑ ΤΗΝ ΑΥΞΗΣΗ ΠΡΩΤΕΪΝΩΝ ΚΑΙ ΕΝΖΥΜΩΝ ΣΕ ΑΝΘΡΩΠΙΝΕΣ ΓΕΝΕΤΙΚΕΣ ΑΣΘΕΝΕΙΕΣ
Franz et al. Create and preserve: proteostasis in development and aging is governed by Cdc48/p97/VCP
JP2021045158A (ja) Ｐｐｒモチーフを利用したｄｎａ結合性タンパク質およびその利用
Gegg et al. Flattop regulates basal body docking and positioning in mono-and multiciliated cells
Antosch et al. Plant proteins containing high mobility group box DNA-binding domains modulate different nuclear processes
CN104046593A (zh) 一种低免疫原性的人细胞及其制备方法
EP2379577A4 (en) COMPOSITIONS AND METHODS FOR CELL REPROGRAMMING WITHOUT GENETIC MODIFICATION
Li et al. Comparative proteomic analysis of the silkworm middle silk gland reveals the importance of ribosome biogenesis in silk protein production
Pan et al. Inactivation of Nxf2 causes defects in male meiosis and age-dependent depletion of spermatogonia
Israel et al. A framework for TRIM21-mediated protein depletion in early mouse embryos: recapitulation of Tead4 null phenotype over three days
Milenkovic et al. Dynamic interplay between RPL3-and RPL3L-containing ribosomes modulates mitochondrial activity in the mammalian heart
Ukleja et al. Beyond the known functions of the CCR4‐NOT complex in gene expression regulatory mechanisms: new structural insights to unravel CCR4‐NOT mRNA processing machinery
NO20091875L (no) Genetisk ablasjon av PRP genceller ved anvendelse av en malsokt strategi for produksjon av serum
JP2023052678A (ja) 生理学的なｘ染色体不活性化を発生させるための組成物および方法
Cinà et al. CRISPR/Cas9 in male factor infertility
Miller Mechanisms of Size Control in Pipid Frogs
Cheong et al. In silico tandem affinity purification refines an Oct4 interaction list
TW200626724A (en) Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria
Bošković et al. Histone variants and reprogramming in early development
Brothers et al. POL30 alleles in Saccharomyces cerevisiae reveal complexities of the cell cycle and ploidy on heterochromatin assembly

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application